PhaseV to Present Transformative Use of AI for Clinical Development at Upcoming Events
Presentations to Highlight the Power of Advanced Machine Learning for Enhancing Trial Design, Execution and Analysis BOSTON, April 8, 2025...
Pharmaceutical
ProofPilot Chief Strategy Officer Joseph Kim Joins Leadership Council of the Society for Clinical Research Sites
NEW YORK, April 8, 2025 /PRNewswire/ -- ProofPilot, the leading end-to-end Clinical Experience Platform (CXP), is proud to announce that its...
Rapid Dose Therapeutics Provides Update on the Clinical Trial Development and the Commitment to NFL Funded Cannabinoid Research
Burlington, Ontario--(Newsfile Corp. - April 8, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company"), a Canadian biotech...
Psyence BioMed Signs LOI with Southern Star Research to Expand Phase IIb Clinical Trial in Australia
New partnership strengthens Psyence BioMed's global clinical trial capabilities, accelerating the development of psilocybin-assisted therapy for adjustment disorderNew York, New...
Defence Launches Accum Combined with Actinium-225 to Increase Efficacy and Safety of Radio-Immunoconjugate Cancer Therapies
Montreal, Quebec--(Newsfile Corp. - April 8, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"),...
Quibim Announces New Board of Directors To Promote Growth And Strategic Expansion
NEW YORK & VALENCIA, Spain & CAMBRIDGE, England--(BUSINESS WIRE)--#AIinHealthcare--Quibim, the global pioneer in imaging biomarkers for precision medicine, is pleased...
Hospital PMI® at 51%; March 2025 Hospital ISM® Report On Business®
TEMPE, Ariz., April 7, 2025 /PRNewswire/ -- Economic activity in the hospital subsector grew in March for the 19th consecutive month after...
Belong.Life’s Advanced AI Technology Selected to Power New Menopause Support Solution
'Ask Elina' Harnesses Belong's Data and Expertise in Conversational AI to Help Women Navigate Menopause, Manage Symptoms and Explore Options NEW...
DOSIsoft PLANET® Onco Dose receives CE MDR Mark and new FDA 510(k) clearance
PARIS, April 7, 2025 /PRNewswire/ -- DOSIsoft, leading provider of patient-specific imaging and dosimetry software solutions for radiation oncology and nuclear...
Nelipak® Healthcare Packaging Expands Commitment to Serve Customers in Asia-Pacific Region with its Sterile Barrier Medical Packaging Products
Expanding Regional Expertise and Localized Solutions to Meet the Growing Demands of Asia-Pacific Healthcare.CRANSTON, R.I., April 07, 2025 (GLOBE NEWSWIRE)...
Surplus Solutions, an NMS Capital Portfolio Company, Expands Capabilities in Refurbished Laboratory Equipment and Technical Services; Announces Partnership with Certified Genetool
NEW YORK and WOONSOCKET, R.I., April 07, 2025 (GLOBE NEWSWIRE) -- Surplus Solutions LLC (“Surplus Solutions”), a portfolio company of...
Rectify Pharma Announces Publication of BSEP Transporter Biophysical Characterization in Communications Biology
Key structural and mechanistic insights into BSEP transporter mutations that lead to improper protein folding and function Findings have potentially...
Sharecare Names Industry Veteran Elizabeth Delahoussaye as Chief Privacy Officer of Health Data Solutions
ATLANTA , April 07, 2025 (GLOBE NEWSWIRE) -- Sharecare, the health tech company that helps to improve care quality, drive...
Conduit Pharmaceuticals Expands Partnership with Sarborg Limited to Leverage Machine Learning Data Analysis for Pipeline Optimization
Conduit expands its partnership with Sarborg to apply advanced machine learning-driven analysis on clinical data from its AstraZeneca-acquired assets, aiming...
Teva and Samsung Bioepis Announce Biosimilar EPYSQLI® (eculizumab-aagh) Injection Now Available in the United States
EPYSQLI® (eculizumab-aagh) is now available to patients living with difficult-to-treat rare diseases like paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome...
Aspargo Labs Expands Global Leadership Team
NEW YORK, April 07, 2025 (GLOBE NEWSWIRE) -- Aspargo Labs, Inc. ("Aspargo Labs" or the "Company"), a specialty pharmaceutical and...
Medexus Provides Update on Progress of Commercialization of GRAFAPEX (treosulfan) for Injection
Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - April 7, 2025) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) is pleased to...
Anavex Life Sciences Announces Positive up to 4-Years Oral Blarcamesine Results from Phase IIb/III Open-Label Extension Trial in Early Alzheimer’s Disease
ATTENTION-AD trial data through 192 weeks presented at AD/PDTM 2025 Conference Prespecified delayed-start analysis indicate disease-modifying effect of oral blarcamesine...
BREAKTHROUGH PRIZE ANNOUNCES 2025 LAUREATES IN LIFE SCIENCES, FUNDAMENTAL PHYSICS, AND MATHEMATICS
"Oscars® of Science" Awards Six $3 Million Prizes GLP-1 Diabetes and Obesity Discovery | Multiple Sclerosis Causes and Treatments | DNA...
BIZCLIK MEDIA PUBLISHES APRIL EDITION OF HEALTHCARE DIGITAL
The April edition of Healthcare Digital features exclusive insights from leaders at Abzena, Arcutis Biotherapeutics, Spotfire, S&P Global Ratings, the FDA, and...